These results showed that the potential of extracellular HMGB1 released from colorectal cancer cells to exert a paracrine effect on surviving cancer cells enabling them to resist chemoradiotherapy via RAGE-ERK-Drp1 signaling pathway. Here, DNM1L is linked to colorectal cancer.